{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:34:00Z","timestamp":1791473640831,"version":"4.3.4"},"reference-count":55,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JND"],"published-print":{"date-parts":[[2020,6,2]]},"DOI":"10.3233\/jnd-190454","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T14:52:53Z","timestamp":1588949573000},"page":"231-246","source":"Crossref","is-referenced-by-count":36,"title":["Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy"],"prefix":"10.1177","volume":"7","author":[{"given":"Kristin","family":"Strandberg","sequence":"first","affiliation":[{"name":"Department of Protein Science, School of Chemistry, Biotechnology and Health, KTH-Royal Institute of Technology, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcu","family":"Ayoglu","sequence":"additional","affiliation":[{"name":"Department of Protein Science, SciLifeLab, KTH-Royal Institute of Technology, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Roos","sequence":"additional","affiliation":[{"name":"MRC Centre for Neuromuscular Diseases, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK"},{"name":"Leibniz-Institut f\u00fcr Analytische Wissenschaften (ISAS), Dortmund, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojgan","family":"Reza","sequence":"additional","affiliation":[{"name":"MRC Centre for Neuromuscular Diseases, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Niks","sequence":"additional","affiliation":[{"name":"Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Signorelli","sequence":"additional","affiliation":[{"name":"Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Fasterius","sequence":"additional","affiliation":[{"name":"Department of Protein Science, School of Chemistry, Biotechnology and Health, KTH-Royal Institute of Technology, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Pont\u00e9n","sequence":"additional","affiliation":[{"name":"Department of Immunology, SciLifeLab, Genetics and Pathology, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanns","family":"Lochm\u00fcller","sequence":"additional","affiliation":[{"name":"MRC Centre for Neuromuscular Diseases, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK"},{"name":"Department of Neuropediatrics and Muscle Disorders, Medical Center \u2013University of Freiburg, Faculty of Medicine, Freiburg, Germany"},{"name":"Centro Nacional de An\u00e1lisis Gen\u00f3mico (CNAGCRG), Center for Genomic Regulation, Barcelona Institute of Science and Technology (BIST), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Domingos","sequence":"additional","affiliation":[{"name":"The Dubowitz Neuromuscular Centre, UCL Institute of Child Health, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierpaolo","family":"Ala","sequence":"additional","affiliation":[{"name":"The Dubowitz Neuromuscular Centre, UCL Institute of Child Health, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Muntoni","sequence":"additional","affiliation":[{"name":"The Dubowitz Neuromuscular Centre, UCL Institute of Child Health, London, UK"},{"name":"National Institute for Health Research, Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke","family":"Aartsma-Rus","sequence":"additional","affiliation":[{"name":"MRC Centre for Neuromuscular Diseases, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK"},{"name":"Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Spitali","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nilsson","sequence":"additional","affiliation":[{"name":"Department of Protein Science, SciLifeLab, KTH-Royal Institute of Technology, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Al-Khalili","family":"Szigyarto","sequence":"additional","affiliation":[{"name":"Department of Protein Science, School of Chemistry, Biotechnology and Health, KTH-Royal Institute of Technology, Stockholm, Sweden"},{"name":"Department of Protein Science, SciLifeLab, KTH-Royal Institute of Technology, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JND-190454_ref1","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3389\/fgene.2017.00084","article-title":"More Is Better: Recent Progress in Multi-Omics Data Integration Methods","volume":"8","author":"Huang","year":"2017","journal-title":"Front Genet"},{"key":"10.3233\/JND-190454_ref2","doi-asserted-by":"publisher","first-page":"P157","DOI":"10.1186\/1745-6215-16-S2-P157","article-title":"Reviewing the evidence supporting predictive biomarkers in European medicines agency indications and contraindications using visual plots","volume":"16","author":"Malottki","year":"2015","journal-title":"Trials"},{"key":"10.3233\/JND-190454_ref3","doi-asserted-by":"publisher","first-page":"e004188","DOI":"10.1136\/bmjopen-2013-004188","article-title":"Stratified medicine in European Medicines Agency licensing: a systematic review of predictive biomarkers","volume":"4","author":"Malottki","year":"2014","journal-title":"BMJ Open"},{"key":"10.3233\/JND-190454_ref4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.copbio.2017.12.011","article-title":"The building blocks of successful translation of proteomics to the clinic","volume":"51","author":"Kearney","year":"2018","journal-title":"Curr Opin Biotechnol"},{"key":"10.3233\/JND-190454_ref5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1559-0275-10-13","article-title":"Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges","volume":"10","author":"F\u00fcz\u00e9ry","year":"2013","journal-title":"Clin Proteomics"},{"key":"10.3233\/JND-190454_ref6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jprot.2013.04.020","article-title":"Profiling post-centrifugation delay of serum and plasma with antibody bead arrays","volume":"95","author":"Qundos","year":"2013","journal-title":"J Proteomics"},{"key":"10.3233\/JND-190454_ref7","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1002\/ajmg.a.38326","article-title":"Drug discovery and development for rare genetic disorders","volume":"173","author":"Sun","year":"2017","journal-title":"Am J Med Genet A"},{"key":"10.3233\/JND-190454_ref8","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1080\/14789450.2016.1202768","article-title":"Understanding the molecular consequences of inherited muscular dystrophies: advancements through proteomic experimentation","volume":"13","author":"Fuller","year":"2016","journal-title":"Expert Rev Proteomics"},{"key":"10.3233\/JND-190454_ref9","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/gt.2014.53","article-title":"Exon skipping restores dystrophin expression, but fails to prevent disease progression in later stage dystrophic dko mice","volume":"21","author":"Wu","year":"2014","journal-title":"Gene Ther"},{"key":"10.3233\/JND-190454_ref10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part implementation of multidisciplinary care","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.3233\/JND-190454_ref11","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","article-title":"The muscular dystrophies","volume":"359","author":"Emery","year":"2002","journal-title":"The Lancet"},{"key":"10.3233\/JND-190454_ref12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-7374-3_1","article-title":"An Overview of Recent Therapeutics Advances for Duchenne Muscular Dystrophy","volume":"1687","author":"Mah","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.3233\/JND-190454_ref13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.nmd.2013.11.015","article-title":"Reliability of the walking energy cost test and the six-minute walk test in boys with Duchenne muscular dystrophy","volume":"24","author":"Kempen","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.3233\/JND-190454_ref14","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/mus.23905","article-title":"The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study","volume":"48","author":"McDonald","year":"2013","journal-title":"Muscle & Nerve"},{"key":"10.3233\/JND-190454_ref15","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.nmd.2010.06.014","article-title":"North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy","volume":"20","author":"Mazzone","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"10.3233\/JND-190454_ref16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.nmd.2014.09.015","article-title":"Suitability of North Star Ambulatory Assessment in young boys with Duchenne muscular dystrophy","volume":"25","author":"De Sanctis","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"10.3233\/JND-190454_ref17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1136\/jnnp-2014-309405","article-title":"The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials","volume":"87","author":"Ricotti","year":"2016","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.3233\/JND-190454_ref18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/dmcn.12922","article-title":"Neurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations","volume":"58","author":"Ricotti","year":"2016","journal-title":"Dev Med Child Neurol"},{"key":"10.3233\/JND-190454_ref19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2214\/AJR.07.2732","article-title":"Three-Point Technique of Fat Quantification of Muscle Tissue as a Marker of Disease Progression in Duchenne Muscular Dystrophy: Preliminary Study","volume":"190","author":"Wren","year":"2012","journal-title":"American Journal of Roentgenology.W"},{"key":"10.3233\/JND-190454_ref20","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1212\/WNL.0000000000000775","article-title":"Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS","volume":"83","author":"Arpan","year":"2014","journal-title":"Neurology"},{"key":"10.3233\/JND-190454_ref21","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.nmd.2014.03.013","article-title":"Assessment of intramuscular lipid and metabolites of the lower leg using magnetic resonance spectroscopy in boys with Duchenne muscular dystrophy","volume":"24","author":"Lott","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.3233\/JND-190454_ref22","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.1007\/s00018-013-1396-z","article-title":"Ongoing therapeutic trials and outcome measures for Duchenne muscular dystrophy","volume":"70","author":"Govoni","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"10.3233\/JND-190454_ref23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1023\/A:1006974613418","article-title":"Creatine kinase, cell membrane and Duchenne muscular dystrophy","volume":"190","author":"Ozawa","year":"1999","journal-title":"Mol Cell Biochem"},{"key":"10.3233\/JND-190454_ref24","doi-asserted-by":"publisher","first-page":"918","DOI":"10.15252\/emmm.201303724","article-title":"Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies","volume":"6","author":"Ayoglu","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.3233\/JND-190454_ref25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/clinchem\/37.1.36","article-title":"Carbonic anhydrase III in serum in muscular dystrophy and other neurological disorders: relationship with creatine kinase","volume":"37","author":"Ohta","year":"1991","journal-title":"Clinical Chemistry"},{"key":"10.3233\/JND-190454_ref26","doi-asserted-by":"publisher","DOI":"10.1186\/1751-0147-54-34"},{"key":"10.3233\/JND-190454_ref27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/DNND.S121099","article-title":"Biomarkers of Duchenne muscular dystrophy: current findings","volume":"8","author":"Szigyarto","year":"2018","journal-title":"Dnnd"},{"key":"10.3233\/JND-190454_ref28","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3233\/JND-140066","article-title":"Muscle-Derived Proteins as Serum Biomarkers for Monitoring Disease Progression in Three Forms of Muscular Dystrophy","volume":"2","author":"Burch","year":"2015","journal-title":"J Neuromuscul Dis"},{"key":"10.3233\/JND-190454_ref29","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3892\/ijmm.2012.1006","article-title":"Proteomics reveals drastic increase of extracellular matrix proteins collagen and dermatopontin in the aged mdx diaphragm model of Duchenne muscular dystrophy","volume":"30","author":"Carberry","year":"2012","journal-title":"Int J Mol Med"},{"key":"10.3233\/JND-190454_ref30","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1096\/fj.06-7285com","article-title":"Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression","volume":"21","author":"Pescatori","year":"2007","journal-title":"Faseb J"},{"key":"10.3233\/JND-190454_ref31","doi-asserted-by":"publisher","first-page":"7153","DOI":"10.1073\/pnas.1507719112","article-title":"Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy","volume":"112","author":"Hathout","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.3233\/JND-190454_ref32","doi-asserted-by":"publisher","first-page":"S251","DOI":"10.1016\/j.nmd.2015.06.242","article-title":"Identification of novel therapy-responsive protein biomarkers for Duchenne muscular dystrophy by aptamer-based serum proteomics","volume":"25","author":"Coenen-Stass","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"10.3233\/JND-190454_ref33","first-page":"13","article-title":"Evaluation of neural damage in Duchenne muscular dystrophy patients","volume":"33","author":"Salam","year":"2014","journal-title":"Acta Myol"},{"key":"10.3233\/JND-190454_ref34","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1021\/pr700890b","article-title":"Antibody suspension bead arrays within serum proteomics","volume":"7","author":"Schwenk","year":"2008","journal-title":"J Proteome Res"},{"key":"10.3233\/JND-190454_ref35","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/10618600.1996.10474713","article-title":"R: A Language for Data Analysis and Graphics","volume":"5","author":"Ihaka","year":"1996","journal-title":"Journal of Computational and Graphical Statistics"},{"key":"10.3233\/JND-190454_ref36","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s11306-011-0350-z","article-title":"State-of-the art data normalization methods improve NMR-based metabolomic analysis","volume":"8","author":"Kohl","year":"2012","journal-title":"Metabolomics"},{"key":"10.3233\/JND-190454_ref37","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1021\/ac051632c","article-title":"Probabilistic Quotient Normalization as Robust Method to Account for Dilution of Complex Biological Mixtures","volume":"78","author":"Dieterle","year":"2006","journal-title":"Application in 1H NMR Metabonomics. Anal Chem"},{"key":"10.3233\/JND-190454_ref38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2307\/2336267","article-title":"Longitudinal Data Analysis Using Generalized Linear Models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"key":"10.3233\/JND-190454_ref39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v015.i02","article-title":"The R Package geepack for Generalized Estimating Equations","volume":"15","author":"Halekoh","year":"2006","journal-title":"J Stat Softw"},{"key":"10.3233\/JND-190454_ref41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.3233\/JND-190454_ref42","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nprot.2012.016","article-title":"Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks","volume":"7","author":"Trapnell","year":"2012","journal-title":"Nat Protoc"},{"key":"10.3233\/JND-190454_ref43","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/prca.201300072","article-title":"Fibronectin is a serum biomarker for Duchenne muscular dystrophy","volume":"8","author":"Cynthia Martin","year":"2014","journal-title":"Proteomics Clin Appl"},{"key":"10.3233\/JND-190454_ref44","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1038\/s41467-018-06642-y","article-title":"Enhanced validation of antibodies for research applications","volume":"9","author":"Edfors","year":"2018","journal-title":"Nat Commun"},{"key":"10.3233\/JND-190454_ref45","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/nbt1210-1248","article-title":"Towards a knowledge-based Human Protein Atlas","volume":"28","author":"Uhl\u00e9n","year":"2010","journal-title":"Nat Biotech"},{"key":"10.3233\/JND-190454_ref46","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1074\/mcp.M113.035600","article-title":"Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics","volume":"13","author":"Fagerberg","year":"2014","journal-title":"Mol Cell Proteomics"},{"key":"10.3233\/JND-190454_ref47","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nmeth.3995","article-title":"A proposal for validation of antibodies","volume":"13","author":"Uhl\u00e9n","year":"2016","journal-title":"Nat Methods"},{"key":"10.3233\/JND-190454_ref48","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.phrs.2018.09.007","article-title":"Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug","volume":"136","author":"Conklin","year":"2018","journal-title":"Pharmacological Research"},{"key":"10.3233\/JND-190454_ref49","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1093\/hmg\/ddy432","article-title":"Transcriptome alterations in myotonic dystrophy skeletal muscle and heart","volume":"28","author":"Wang","year":"2019","journal-title":"Human Molecular Genetics"},{"key":"10.3233\/JND-190454_ref50","doi-asserted-by":"publisher","first-page":"10488","DOI":"10.1038\/ncomms10488","article-title":"The lack of the Celf2a splicing factor converts a Duchenne genotype into a Becker phenotype","volume":"7","author":"Martone","year":"2016","journal-title":"Nat Commun"},{"key":"10.3233\/JND-190454_ref51","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrclinonc.2014.202","article-title":"Pragmatic issues in biomarker evaluation for targeted therapies in cancer","volume":"12","author":"de Gramont","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"10.3233\/JND-190454_ref52","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/jcsm.12304","article-title":"Tracking disease progression non-invasively in Duchenne and Becker muscular dystrophies","volume":"80","author":"Spitali","year":"2018","journal-title":"J Cachexia, Sarcopenia Muscle"},{"key":"10.3233\/JND-190454_ref53","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3233\/JND-140011","article-title":"Mass Spectrometry-Based Identification of Muscle-Associated and Muscle-Derived Proteomic Biomarkers of Dystrophinopathies","volume":"1","author":"Dowling","year":"2014","journal-title":"J Neuromuscul Dis"},{"key":"10.3233\/JND-190454_ref54","doi-asserted-by":"publisher","first-page":"43697","DOI":"10.1038\/srep43697","article-title":"Identification of serum protein biomarkers for utrophin based DMD therapy","volume":"7","author":"Guiraud","year":"2017","journal-title":"Sci Rep"},{"key":"10.3233\/JND-190454_ref55","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1002\/pmic.200401181","article-title":"Proteomic analysis of slow- and fast-twitch skeletal muscles","volume":"5","author":"Okumura","year":"2005","journal-title":"Proteomics"},{"key":"10.3233\/JND-190454_ref56","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/ppul.22847","article-title":"Respiratory Muscle Decline in Duchenne Muscular Dystrophy","volume":"49","author":"Khirani","year":"2014","journal-title":"Pediatr Pulmonol"}],"container-title":["Journal of Neuromuscular Diseases"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JND-190454","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:49:27Z","timestamp":1777506567000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JND-190454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,2]]},"references-count":55,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jnd-190454","relation":{},"ISSN":["2214-3599","2214-3602"],"issn-type":[{"value":"2214-3599","type":"print"},{"value":"2214-3602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,2]]}}}